27.07.2018 • NewsSABICClariantM%26A

SABIC’s Purchase of Clariant Stake Delayed

Das neue Werk in Jiaxing wird der am stärksten digitalisierte Standort des...
Das neue Werk in Jiaxing wird der am stärksten digitalisierte Standort des Unternehmens mit komplexen Automatisierungssystemen über den gesamten Produktionsprozess sein. Foto: Clariant

Plans by Saudi Arabian petrochemicals giant SABIC to acquire a nearly 25% stake in Swiss specialty chemicals producer Clariant are being held up by outstanding antitrust approvals, but the deal is not threatened, the Swiss group’s CEO Hariolf Kottmann said during an earnings conference call on Jul. 24.

Regulatory clearance from countries such as Brazil and Mexico is still forthcoming, Kottmann said, adding that this means that management’s plans to give investors an update in September on Clariant’s future plans in light of the new ownership situation could have to be put on hold.

While analysts have speculated that SABIC could be interested in buying more of Clariant, if not all of it, Kottmann said this discussion is premature, as the companies' two sides have not yet been able to hold detailed talks.

“Clariant remains the top takeover candidate in the sector,” Baader Helvea analyst Markus Mayer told the news agency Reuters. However, Kottmann said it does not appear that SABIC wants to acquire any additional shares.

From the current point of view, the CEO said, talk of a complete takeover “makes no sense, because I think now we are in a much earlier stage and phase of discussions where we have the obligation to find value-creating potentials for our shareholders.”

Recently confirmed plans by compatriot Saudi Aramco to acquire part of the Saudi government’s indirect 70% stake in SABIC, held by the Public Investment Fund (PIF), will not have any influence on the chemical producer’s plans for the Clariant purchase, Kottmann remarked.

In January of this year, SABIC emerged as a white knight to acquire shares in the Swiss group from White Tale, the acquisition vehicle of funds Corvex and 40 North, which had torpedoed Clariant’s plans to merge with US competitor Huntsman.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.